Skip to main content
Login
User menu
Mega menu
EASL.eu
Resources
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Molecular Tumour Boards
EASL Genetic Grand Round
EASL Policy Dialogues
EASL Quiz
ePosters
EASL DeepDive
EASL Journal Club
Nurses and AHPs
Online Courses
On-demand Webinars
Podcasts
Slide Decks
Webcasts
Webinars Calendar
EASL-Related Resources
EHC On-demand Webinar
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - EASL Monothematic Conference 2023
Industry Symposia - EASL Congress
Industry Symposia - EASL Liver Cancer Summit
Industry Symposia - EASL SLD Summit
GSK Resources
Patient Resources
All Resources
COVID-19 Resources
Documents
ePosters
Infographics
Patient Guidelines
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
Primary tabs
User menu
Resources 98
Session 98
(current)
Displaying 1 - 12 of 98
Display:
12
24
48
Viral Hepatitis
6
AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
5
GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
7
GSK: "Practical tips towards providing holistic care to patients with PBC" - EASL Congress 2023
View
Viral Hepatitis
5
GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023
View
Metabolism, Alcohol & Toxicity
1
Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" - EASL Congress 2023
View
Viral Hepatitis
5
Gilead: "Headlines In Hepatitis Delta: The Latest Advances In Care in Hepatitis Delta" - EASL Congress 2023
View
Viral Hepatitis
3
Gilead: “From Headlines To The Clinic: Expert Approaches To Patient Care in Hepatitis Delta” - EASL Congress 2023
View
General Hepatology
5
Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023
View
Viral Hepatitis
1
GSK: "Looking To The Future Of Hepatitis B: An Expert Review Of Quantitative Hepatitis B Surface Antigen Assessment” - EASL Congress 2023
View
Metabolism, Alcohol & Toxicity
6
Takeda: "Alpha-1 antitrypsin deficiency (AATD) - Associated liver disease: More common than you may think" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
1
Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
1
Ipsen: "Scratching beyond the surface in PBC: From current unmet medical needs to future prospects" - EASL Congress 2023
View
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Next page
next ›
Last page
Last »
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy